Fig. 9From: A robust blood gene expression-based prognostic model for castration-resistant prostate cancerSurvival curve of high- and low-risk group in the second validation set based on Wang_4genescore when all patients are considered (a) and when patients with visceral metastasis or under the third line treatment are removed (b)Back to article page